#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) – European Heart Journal

Commentary: Colchicine Cardiovascular Outcomes Trial – COLCOT – American College of Cardiology

Commentary on Twitter

#ESCCongress #COLCOT Study looking at TTI colchicine to assess if timing impacted outcomes
❤️ACS treatment with colchicine 🆚 placebo: 23%⤵️ in events
❤️Randomized w/in 30days postMI
🔺TTI (Time to Treat Initiation) 0-3d 🆚 4-7d 🆚 8-30d
🔺0-3 days had better outcomes pic.twitter.com/iQAkts1BG9

— Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@DrMarthaGulati) August 30, 2020